WAVE Life Sciences Ltd.
WVE
$6.59
$0.0450.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -82.16% | -68.67% | -67.73% | 44.00% | 59.27% |
| Total Depreciation and Amortization | -3.30% | -5.90% | -8.72% | -10.77% | -10.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.26% | 34.16% | 18.21% | -3.86% | -37.90% |
| Change in Net Operating Assets | 3.58% | -497.37% | -141.89% | -175.59% | -177.71% |
| Cash from Operations | -30.53% | -677.24% | -616.26% | -1,088.39% | -5,699.87% |
| Capital Expenditure | 34.23% | 15.87% | -25.44% | 16.28% | 36.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 34.23% | 15.87% | -105.02% | -104.30% | -102.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 104.89% | 80.95% | 673.40% | 199.11% | 29.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 352,600.00% | -- | -- |
| Cash from Financing | 117.46% | 91.57% | 709.98% | 199.66% | 10.96% |
| Foreign Exchange rate Adjustments | 95.95% | -45.26% | 138.98% | -25.24% | -2.07% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 325.52% | -9.03% | 297.68% | -138.04% | -118.78% |